The Simms/Mann - UCLA Center for Integrative Oncology is part of UCLA's Jonsson Comprehensive Cancer Center and UCLA Oncology. To find out more about research opportunities and medical oncology care, please visit these sites.
simmsmanncenter@mednet.ucla.edu

Posts

Phone: (310) 794-6644 Fax: (310) 794-9615
Mon - Fri: 8:00AM - 5:00PM Sat - Sun: Closed
Email simmsmanncenter@mednet.ucla.edu

Insights Into Cancer – July 12, 2016

Pancreatic Cancer 2016: Surgical and Medical Treatment

Presented by Timothy R. Donahue, MD and Zev Wainberg, MD

About the Lecture

Pancreatic cancer is the fourth most common cause of cancer related deaths in the United States. It is the second most common cause of gastrointestinal cancers, behind colon cancer. Patients often do not experience symptoms until the cancer involves the surrounding blood vessels or spreads beyond the pancreas, and they are initially treated with chemotherapy and occasionally radiation therapy. Surgical treatment is offered to patients with early stage tumors that are confined to the region of the pancreas; it includes a Whipple resection, which is a complex surgery. This lecture will address the surgical and medical treatment of patients with both early and late stage disease. Up to date information on improved survival associated with chemotherapy regimens and biologic agents will be reviewed. We will also highlight the diverse resources that are available within the UCLA Center for Pancreatic Diseases, including clinical trials, palliative treatments, support services, etc.

About the Speakers

Dr. Timothy Donahue is Chief of Gastrointestinal and Pancreatic Surgery, and an Associate Professor of Surgery at the David Geffen School of Medicine at UCLA. He also has a joint appointment in the Department of Molecular and Medical Pharmacology to facilitate his research program. Dr. Donahue is the Director of the General Surgery Residency Program. He is a very busy pancreatic surgeon and performs three to four pancreatic surgeries per week. He is genuinely interested in caring for patients with pancreatic cancer and making sure they receive state-of-the art care. In addition to his clinical work, Dr. Donahue is the Principal Investigator of a National Institutes of Health funded research laboratory. His scientific research focuses on developing new drugs and better treatment strategies for patients with pancreatic cancer. To do so, he collaborates with numerous other researchers across the UCLA campus.

Zev Wainberg, MD is an Assistant Professor in the Department of Medicine, Division of Hematology/Oncology at the David Geffen School of Medicine UCLA. As a medical oncologist who specializes in gastrointestinal cancers, Dr. Wainberg has an active practice and has many clinical trials devoted to these diseases. Dr. Zev Wainberg received his MD from Tel Aviv University Sackler School of Medicine, New York Program in 2000. He did his internship and residency in Internal Medicine at Montefiore Medical Center Moses Division Hospital, Albert Einstein College of Medicine, from 2000-2003. He completed his three-year fellowship in Hematology-Oncology at the David Geffen School of Medicine at UCLA in 2006. He is the Co-director of the UCLA Gastro-Intestinal Oncology Program and the medical director of the UCLA Colorectal Cancer Center. He is certified in Internal Medicine, Hematology, and Oncology.

Contact us for more information or book an appointment